Bgm BGM
NASDAQ BGM
$0.25 +0.01 (+4.62%)
As of: Sep 29, 2026 · 3:59 PM EDT

Bgm (BGM) Work In Process (2019 - 2025)

Updated

Bgm (BGM) recorded Work In Process of $326,813 in fiscal Q4 2025 (quarter ended Sep 30, 2025), down 18.3% from $400,253 a year earlier.

Analysis

Bgm (BGM) Work In Process (2019 - 2025) Analysis & Trends

Starting with fiscal Q4 2019, Bgm's Work In Process history includes 9 quarters.

  • Annual Work In Process has a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
  • Across earlier fiscal years, Work In Process came in at $400,253 in FY2024 (+68.2%), $237,987 in FY2023 (-68.2%), $748,845 in FY2022 (-10.0%) and $832,499 in FY2021 (+18.1%).
  • Quarterly Work In Process has ranged from $237,987 in fiscal Q4 2023 to $832,499 in fiscal Q4 2021 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Bgm 27.18 Mn -4,800.01 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 326,813.00
Mar 31, 2025 289,148.00
Sep 30, 2024 400,253.00
Mar 31, 2024 343,898.00
Sep 30, 2023 237,987.00
Sep 30, 2022 748,845.00
Sep 30, 2021 832,499.00
Sep 30, 2020 704,991.00
Sep 30, 2019 1.15 Mn
API Access

Bgm Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=BGM&period=max&api_key=YOUR_API_KEY